|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 239/48 | (2006.01) |
| C07D 239/48 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Patento numeris | 3788035 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19726240.5 |
| Europos patento paraiškos padavimo data | 2019-05-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-03-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-08-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2019/030717 |
| Data | 2019-05-03 |
| (87) | Numeris | WO 2019/213606 |
| Data | 2019-11-07 |
| (30) | Numeris | Data | Šalis |
| 201862667226 P | 2018-05-04 | US |
| (72) |
PANDEY, Anjali , US
NORTHEN, Julian Scott , GB
FERNANDES, Philippe , GB
CHEN, Ying , US
LU, Yuelie , US
KARABORNI, Sami , US
KODERSHA, Gus , US
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | SOLID FORMS OF CERDULATINIB |
| SOLID FORMS OF CERDULATINIB |